LFA-1/ICAM-1 interaction inhibitors (Genentech/Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameLFA-1/ICAM-1 interaction inhibitors (Genentech/Roche)
Drug Alias NameMac-1/ICAM-1 interaction inhibitors (Genentech)Mac-1/ICAM-1 interaction inhibitors (Roche)LFA-1/ICAM-1 interaction inhibitors (Roche)CP151088RO-5184438 +[10] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionIntegrin alpha-M modulatorsImmunomodulatorsIntercellular adhesion molecule-1 modulators +[4] 
TargetsIntegrin alpha-MIntercellular adhesion molecule-1Leukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech IncHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A